PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Quitting smoking: Licensed medications are effective

2013-05-31
(Press-News.org) Nicotine replacement therapy and other licensed drugs can help people quit smoking, according to a new systematic review published in The Cochrane Library. The study, which is an overview of previous Cochrane reviews, supports the use of the smoking cessation medications that are already widely licensed internationally, and shows that another drug licensed in Russia could hold potential as an effective and affordable treatment.

In Europe and the US the only medications currently licensed for smoking cessation are nicotine replacement therapies (NRTs) such as nicotine patches and gums, the antidepressant bupropion and the drug varenicline, which blunts the effects of nicotine on nicotine receptors in the brain. In Russia and other parts of Eastern Europe cytisine, which is similar to varenicline, is also licensed for smoking cessation.

The authors combined the findings of existing Cochrane reviews on the subject, using all the available data from across the individual reviews. In total, they collected evidence from 267 studies, which together involved a total of 101,804 people. The studies covered a wide variety of licensed and unlicensed smoking cessation medications, comparing the treatments with placebo, and the three main treatments with each other. If a person stopped smoking for six months or longer, this was considered a successful quit attempt.

The three widely licensed medications and cytisine all improved smokers' chances of quitting. The odds of quitting were about 80% higher with single NRTor bupropion than with placebo, and between two and three times higher with varenicline than with placebo. However, Varenicline was about 50% more effective than any single formulation of NRT (patches, gum, sprays, lozenges and inhalers), but similar in efficacy to combining two types of NRT. Based on two recent trials, cytisine improved the chances of quitting nearly four-fold compared with placebo. Among other treatments tested, nortriptyline, another antidepressant drug, was more effective than placebo but did not offer any additional improvement when combined with NRT.

"This review provides strong evidence that the three main treatments, nicotine replacement therapy, bupropion and varenicline, can all help people to stop smoking," said lead researcher Kate Cahill of the Department of Primary Care Health Sciences at the University of Oxford in Oxford, UK. "Although cytisine is not currently licensed for smoking cessation in most of the world, these data suggest it has potential as an effective and affordable therapy."

The researchers also assessed the safety of different medications. Bupropion, which is known to trigger occasional seizures in vulnerable people, did not lead to an increase in the rate of seizures when used for smoking cessation in its slow-release version. Overall, NRT, bupropion and varenicline are considered low risk treatments, although the researchers say the results are currently less clear-cut for varenicline.

"Further research may be warranted into the safety of varenicline," said Cahill. "However, in the trials we looked at we did not detect evidence of any increase in neuropsychiatric, heart or circulatory problems."

### END


ELSE PRESS RELEASES FROM THIS DATE:

Probiotics prevent diarrhoea related to antibiotic use

2013-05-31
Probiotic supplements have the potential to prevent diarrhoea caused by antibiotics, according to a new Cochrane systematic review. The authors studied Clostridium difficile (C. difficile) infections in patients taking antibiotics and found symptoms of diarrhoea were substantially reduced when patients were also treated with probiotics. Antibiotics disturb the beneficial bacteria that live in the gut and allow other harmful bacteria like C. difficile to take hold. Although some people infected with C. difficile show no symptoms, others suffer diarrhoea or colitis. The ...

Multi-national study identifies links between genetic variants and educational attainment

2013-05-31
A multi-national team of researchers has identified genetic markers that predict educational attainment by pooling data from more than 125,000 individuals in the United States, Australia, and 13 western European countries. The study, which appears in the journal Science, was conducted by the Social Science Genetic Association Consortium (SSGAC), which includes researchers at NYU, Erasmus University, Cornell University, Harvard University, the University of Bristol, and the University of Queensland, among other institutions. The SSGAC conducted what is called a genome-wide ...

Atom by atom, bond by bond, a chemical reaction caught in the act

2013-05-31
When Felix Fischer of the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) set out to develop nanostructures made of graphene using a new, controlled approach to chemical reactions, the first result was a surprise: spectacular images of individual carbon atoms and the bonds between them. "We weren't thinking about making beautiful images; the reactions themselves were the goal," says Fischer, a staff scientist in Berkeley Lab's Materials Sciences Division (MSD) and a professor of chemistry at the University of California, Berkeley. "But ...

Good kidney health begins before birth

2013-05-31
Researchers have found that conditions in the womb can affect kidney development and have serious health implications for the child not only immediately after birth, but decades later. In a paper published today in The Lancet an international team, including Monash University's Professor John Bertram and the University of Queensland's Professor Wendy Hoy, reviewed existing, peer-reviewed research on kidney health and developmental programming - the effects of the in utero environment on adult health. The accumulated evidence linked low birth weight and prematurity ...

Is enough being done to make drinking water safe?

2013-05-31
There is a lack of evidence regarding the effectiveness of technologies used to reduce arsenic contamination finds research in BioMed Central's open access journal Environmental Evidence. More studies assessing the technologies themselves and how they are used in the community are needed to ensure that people have access to safe, clean water. Arsenic is now recognised to be one of the world's greatest environmental hazards, threatening the lives of several hundred million people. Naturally occurring arsenic leaches into water from surrounding rocks and once in the water ...

Getting better without antibiotics

2013-05-31
Given the option, many women with symptoms of urinary tract infections are choosing to avoid antibiotics and give their bodies a chance to heal naturally, finds research in BioMed Central's open access journal BMC Family Practice. The research shows that 70% of women with symptoms of uncomplicated urinary tract infections who did not use antibiotics for a week were cured or showed improvement. Antimicrobial-resistant bacteria are already a big problem and the incidence of 'superbugs', which are resistant to several antibiotics, is on the rise. Over use of antibiotics ...

No benefit of double dose antiviral drug for severe influenza

2013-05-31
This is the first study to examine the effectiveness of higher doses of oseltamivir in cases of hospitalized severe human influenza (seasonal, pandemic and bird flu strains). The authors say their findings have implications for global guidelines, clinical management and pandemic preparedness, including for the current H7N9 outbreak. Human influenza is usually a self-limiting illness. Occasionally, however, it can lead to respiratory complications, admission to hospital, and death. Some studies suggest that, if given early, oseltamivir can help reduce mortality. This has ...

Why animals compare the present with the past

2013-05-31
According to standard theory, the best response to current circumstances should be unaffected by what has happened in the past. But the Bristol study, published in the leading journal Science, shows that in a changing, unpredictable world it is important to be sensitive to past conditions. The research team, led by Professor John McNamara in Bristol's School of Mathematics, built a mathematical model to understand how animals should behave when they are uncertain about the pattern of environmental change. They found that when animals are used to rich conditions but ...

Frontiers news briefs May 30

2013-05-31
Frontiers in Psychology When language switching has no apparent cost: Lexical access in sentence context Bilinguals have the remarkable ability to switch from one language to the other. In a new study, Jason Gullifer and colleagues from Pennsylvania State University, USA, looked at whether language switching incurs a processing cost. They show that the mind has little difficulty in preventing such mix-ups between languages. When 26 North American Latino people were asked to read aloud an underlined word within a text that mixed English and Spanish, they did not think ...

Ancient streambed found on surface of Mars

2013-05-31
Rounded pebbles on the surface of Mars indicate that a stream once flowed on the red planet, according to a new study by a team of scientists from NASA's Curiosity rover mission, including a University of California, Davis, geologist. The study will be published in the May 31 issue of the journal Science. Rounded pebbles of this size are known to form only when transported through water over long distances. They were discovered between the north rim of the planet's Gale Crater and the base of Mount Sharp, a mountain inside the crater. The finding represents the first ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Quitting smoking: Licensed medications are effective